You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine Tumors

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Neuroendocrine Tumors Trial in São Paulo (MIBG-I131)

Withdrawn
  • Neuroendocrine Tumors
  • MIBG-I131
  • São Paulo, SP, Brazil
    AC Camargo Cancer Center
May 13, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Gastroenteropancreatic Neuroendocrine Tumours

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumor
  • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
  • Milano, Italy
    Irccs San Raffaele
Nov 24, 2023

Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)

Recruiting
  • Prostate Cancer Metastatic
  • Neuroendocrine Tumors
  • Duarte, California
  • +2 more
Jan 18, 2023

Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Carcinoid Tumor
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
  • +1 more
Nov 8, 2022

Neuroendocrine Tumors Trial in New York (177Lu-DOTA-EB-TATE, Amino Acid Solution)

Recruiting
  • Neuroendocrine Tumors
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 22, 2022

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Neoplasms Methylation Based Classifier - The

Enrolling by invitation
  • Neuroendocrine Tumors
  • Methylation analysis
  • Basel, Basel Stadt, Switzerland
    University Hospital Basel, Department of Endocrinology
May 17, 2022

Gastroenteropancreatic Neuroendocrine Tumors Trial in Marseille ([68Ga]-DOTANOC PET/CT)

Completed
  • Gastroenteropancreatic Neuroendocrine Tumors
  • [68Ga]-DOTANOC PET/CT
  • Marseille, France
    AP-HM
Oct 12, 2022

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 23, 2022

Neuroendocrine Tumors Trial in Edmonton (18F-DOPA with furosemide)

Not yet recruiting
  • Neuroendocrine Tumors
  • 18F-DOPA with furosemide
  • Edmonton, Alberta, Canada
    University of Alberta Hospital
May 23, 2022

Metastatic Neuroendocrine Tumor Trial (Biospecimen Collection, Computed Tomography, Lutetium Lu 177 Dotatate)

Not yet recruiting
  • Metastatic Neuroendocrine Tumor
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Feb 10, 2023

Neuroendocrine Tumors Trial in Toronto (F18-FDG)

Recruiting
  • Neuroendocrine Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2022

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Neuroendocrine Tumors Trial in Sweden (177Lu-DOTATOC, Capecitabine)

Not yet recruiting
  • Neuroendocrine Tumors
  • Göteborg, Sweden
  • +3 more
May 19, 2022

Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, China
    Chinese PLA General Hospital
May 25, 2023

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Neuroendocrine Tumors Trial in Iowa City ([68Ga]Pentixafor)

Recruiting
  • Neuroendocrine Tumors
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center
Mar 16, 2022

Cancer of Stomach, Oesophageal Cancer, Gastric Cancer Trial in Sydney

Recruiting
  • Cancer of Stomach
  • +8 more
    • Sydney, New South Wales, Australia
      Westmead Hospital
    Mar 26, 2023

    Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)

    Recruiting
    • Neuroendocrine Tumor
    • Beijing, Chao Yang, China
      National Cancer Center/Cancer Hospital,Chinese Academy of Medica
    Feb 19, 2023

    Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

    Not yet recruiting
    • Adrenal Cortical Carcinoma
    • +3 more
    • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
    • Shanghai, Shanghai, China
      Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
    Nov 19, 2023

    Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

    Not yet recruiting
    • Metastatic Pancreatic Neuroendocrine Tumor
    • +4 more
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Jan 14, 2023